For more information visit https://www.miltenyibiotec.com/applic... Cellular and structural components surrounding tumor cells make up the tumor microenvironment (TME). Their dynamic interactions define tumor heterogeneity, progression, and metastasis.

Nonmalignant cells in the TME can, for example, change their phenotype and promote tumor development. Unraveling mechanisms and interactions like this on cellular and molecular level enables the identification of new therapeutic strategies to treat cancer. Watch this short intro webinar of our TME miniwebinar series get a quick refresher on the cause and effect of the TME on tumor development. The webinar gives an overview of cellular and noncellular components in the TME, the functional characteristics of the TME, and the role of the TME in drug development.

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 3,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.